After hanging a number of deals to import vaccines, Thammasat University has expressed frustration with how bureaucratic purple tape is delaying the arrival of three million Moderna vaccines donated from Poland. They known as for the government to expedite the process to get the Moderna vaccine into Thailand.
โซล่าเซลล์ that Poland had donated to the college have been scheduled to reach on Tuesday, but the cargo was delayed because the deal waited on official paperwork from the federal government of Thailand. A supply from the university reported that the government mentioned sure to the donation, but they did not submit the required documents to make it official.
The deal between the hospital of Thammasat University and Poland’s vaccine centre was arranged with the assist of the Thonburi Healthcare Group who is facilitating the transportation of the Moderna vaccines from Poland to Thailand, in addition to dealing with the quality-control exams and associated bills.
The delay has frustrated Thammasat University, which had already clashed with the federal government over a lowered distribution of vaccines beforehand, leaving the university brief stocked for administering vaccines which they said slowed them of their battle to comprise Covid-19 outbreaks.
The director of Thammasat University Hospital says they’re still attempting to get the federal government to submit paperwork and receive the vaccines from Poland, as additionally they expect 1.5 million vaccines to arrive by the tip of October. In November, another batch of 2 million Moderna vaccines is scheduled to comply with.
Aside from the 3 million donated vaccines from Poland, Thammasat University has made a deal in late September with a personal hospital to import 5 million Pfizer and Moderna vaccines as well as a second deal to acquire 2 million Moderna vaccines with one other personal hospital.
Thammasat University has additionally made an settlement to conduct trials for an unnamed European vaccine in addition to with a generic drug producer in India for the Molnupiravir antiviral drug made in India..